Statement on humanitarian aid in Ukraine
- Details
- Category: Business
Ugur Sahin, CEO and Co-Founder of BioNTech: "We at BioNTech are closely following the tragic situation in Ukraine and our thoughts are with everyone affected. As a company with employees from 60 countries, we know that diversity and community are stronger than pursuing single-sided interests. We join the call of the global community and urge those involved to return to peaceful coexistence in the region for the sake of all people.
Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
- Details
- Category: Boehringer Ingelheim
The leading research-driven biopharmaceutical company Boehringer Ingelheim and precision medicine software company Lifebit Biotech, Ltd. (Lifebit) today announce partnership in which Lifebit will support Boehringer Ingelheim in building a scalable data, analytics, and infrastructure platform within its IT environment.
Roche announces donation of essential medicines to Ukraine
- Details
- Category: Roche
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential medicines to Ukraine. Roche vehemently condemns the violent invasion of the country.
Roche is working diligently to support the country and people of Ukraine with medical products in accordance with Roche's overall mission and announced today that we are donating 150,000 packages of Rocephin, a critical antibiotic used to treat the symptoms of many kinds of bacterial infections and listed on the World Health Organization's list of essential medicines.
GSK announces independent Consumer Healthcare company is to be called Haleon
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon.
Haleon (pronounced "Hay-Lee-On") is inspired by the merging of the words 'Hale', which is an old English word that means 'in good health' and Leon, which is associated with the word 'strength'.
BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
- Details
- Category: Business
BioNTech SE (Nasdaq: BNTX, "BioNTech") and Medigene AG (FSE: MDG1, Prime Standard, "Medigene"), a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, today announced that they have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer. The initial term of the collaboration is three years.
Bayer delivers on medical innovation fueling transformation of pharma business
- Details
- Category: Bayer
At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients.
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
- Details
- Category: Business
BioNTech SE (Nasdaq: BNTX, "BioNTech") has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution.
More Pharma News ...
- WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
- Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
- Sanofi completes acquisition of Amunix
- Sanofi unveils new corporate brand and logo - unites the company under one purpose and a single identity
- Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
- Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies
- Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment